Long‐term follow‐up of a prospective, double‐blind, placebo‐controlled randomized trial of clodronate in multiple myeloma
Oral clodronate (1600 mg/d) has been shown to significantly reduce the incidence of skeletal complications in multiple myeloma. Preliminary analysis of a double‐blind placebo‐controlled trial of this treatment indicated that clodronate might prolong survival in patients without vertebral fractures a...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Language: | English |
| Published: |
2001
|
| Online Access: | https://doi.org/10.1046/j.1365-2141.2001.02851.x https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2141.2001.02851.x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|